150 related articles for article (PubMed ID: 29688116)
1. Association between altered lipid profiles and attention deficit hyperactivity disorder in boys.
Avcil S
Nord J Psychiatry; 2018 Jul; 72(5):361-366. PubMed ID: 29688116
[TBL] [Abstract][Full Text] [Related]
2. The assessment of serum lipid profiles of children with attention deficit hyperactivity disorder.
Ugur C; Uneri OS; Goker Z; Sekmen E; Aydemir H; Solmaz E
Psychiatry Res; 2018 Jun; 264():231-235. PubMed ID: 29655116
[TBL] [Abstract][Full Text] [Related]
3. Iron Deficiency Parameters in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
Percinel I; Yazici KU; Ustundag B
Child Psychiatry Hum Dev; 2016 Apr; 47(2):259-69. PubMed ID: 26092605
[TBL] [Abstract][Full Text] [Related]
4. Attention-deficit/hyperactivity disorder is associated with reduced levels of serum low-density lipoprotein cholesterol in adolescents. Data from the population-based German KiGGS study.
Pinho R; Wang B; Becker A; Rothenberger A; Outeiro TF; Herrmann-Lingen C; Meyer T
World J Biol Psychiatry; 2019 Jul; 20(6):496-504. PubMed ID: 29243550
[No Abstract] [Full Text] [Related]
5. [Attention deficit/hyperactivity disorder: burden of the disease according to subtypes in recently diagnosed children].
Escobar R; Hervas A; Soutullo C; Mardomingo MJ; Uruñuela A; Gilaberte I
Actas Esp Psiquiatr; 2008; 36(5):285-94. PubMed ID: 18830848
[TBL] [Abstract][Full Text] [Related]
6. The effects of yoga on the attention and behavior of boys with Attention-Deficit/ hyperactivity Disorder (ADHD).
Jensen PS; Kenny DT
J Atten Disord; 2004 May; 7(4):205-16. PubMed ID: 15487477
[TBL] [Abstract][Full Text] [Related]
7. Executive dysfunction screening and intelectual coefficient measurement in children with attention deficit hyperactivity disorder.
Zambrano-Sánchez E; Martínez-Cortés JA; Rió-Carlos YD; Martínez-Wbaldo Mdel C; Poblano A
Arq Neuropsiquiatr; 2010 Aug; 68(4):545-9. PubMed ID: 20730307
[TBL] [Abstract][Full Text] [Related]
8. Atomoxetine response in the inattentive and combined subtypes of attention deficit hyperactivity disorder: a retrospective chart review.
Ercan ES; Akyol Ardic U; Kabukcu Basay B; Ercan E; Basay O
Atten Defic Hyperact Disord; 2013 Dec; 5(4):377-85. PubMed ID: 23737214
[TBL] [Abstract][Full Text] [Related]
9. Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity disorder.
Spivak B; Vered Y; Yoran-Hegesh R; Averbuch E; Mester R; Graf E; Weizman A
Acta Psychiatr Scand; 1999 Apr; 99(4):300-4. PubMed ID: 10223434
[TBL] [Abstract][Full Text] [Related]
10. Thiols and ceruloplasmin levels in serum of children with attention deficit hyperactivity disorder: A cross-sectional study.
Öğütlü H; Mertoğlu C; Gök G; Neşelioğlu S
Psychiatry Res; 2020 Dec; 294():113546. PubMed ID: 33160216
[TBL] [Abstract][Full Text] [Related]
11. Combined type versus ADHD predominantly hyperactive-impulsive type: is there a difference in functional impairment?
Riley C; DuPaul GJ; Pipan M; Kern L; Van Brakle J; Blum NJ
J Dev Behav Pediatr; 2008 Aug; 29(4):270-5. PubMed ID: 18454040
[TBL] [Abstract][Full Text] [Related]
12. The probable role of adrenomedullin and nitric oxide in childhood attention deficit hyperactivity disorder.
Gürbüz Özgür B; Aksu H; Yılmaz M; Karakoç Demirkaya S
Nord J Psychiatry; 2017 Oct; 71(7):521-524. PubMed ID: 28670953
[TBL] [Abstract][Full Text] [Related]
13. Serum zinc correlates with parent- and teacher- rated inattention in children with attention-deficit/hyperactivity disorder.
Arnold LE; Bozzolo H; Hollway J; Cook A; DiSilvestro RA; Bozzolo DR; Crowl L; Ramadan Y; Williams C
J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):628-36. PubMed ID: 16190794
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of atomoxetine in childhood attention-deficit/hyperactivity disorder with comorbid oppositional defiant disorder.
Kaplan S; Heiligenstein J; West S; Busner J; Harder D; Dittmann R; Casat C; Wernicke JF
J Atten Disord; 2004 Oct; 8(2):45-52. PubMed ID: 15801334
[TBL] [Abstract][Full Text] [Related]
15. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
Biederman J; Pliszka SR
J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine, Pyridoxine, Folate and Vitamin B12 Levels in Children with Attention Deficit Hyperactivity Disorder.
Altun H; Şahin N; Belge Kurutaş E; Güngör O
Psychiatr Danub; 2018 Sep; 30(3):310-316. PubMed ID: 30267523
[TBL] [Abstract][Full Text] [Related]
18. Time course of the development of depressive mood and oppositional defiant behavior among boys with attention deficit hyperactivity disorder: differences between subtypes.
Ushijima H; Usami M; Saito K; Kodaira M; Ikeda M
Psychiatry Clin Neurosci; 2012 Jun; 66(4):285-91. PubMed ID: 22624733
[TBL] [Abstract][Full Text] [Related]
19. Serum brain-derived neurotrophic factor levels in treatment-naïve boys with attention-deficit/hyperactivity disorder treated with methylphenidate: an 8-week, observational pretest-posttest study.
Akay AP; Resmi H; Güney SA; Erkuran HÖ; Özyurt G; Sargin E; Topuzoglu A; Tufan AE
Eur Child Adolesc Psychiatry; 2018 Jan; 27(1):127-135. PubMed ID: 28710695
[TBL] [Abstract][Full Text] [Related]
20. Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder.
Newcorn JH; Spencer TJ; Biederman J; Milton DR; Michelson D
J Am Acad Child Adolesc Psychiatry; 2005 Mar; 44(3):240-8. PubMed ID: 15725968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
